Follow the 중앙첨단소재 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 중앙첨단소재 has published 60 reports. Market capitalisation: €106.8bn. The latest transaction was reported on 26 March 2026 (Other). Among the most active insiders: 아틀라스팔천. The full history is free.
60
Insider Decl.
n/a
Thresholds
n/a
8 ops.
Buy Volume
n/a
20 ops.
Sell Volume
5Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 22,618 of 28,199 companies
30.5
score / 100
Value
36
Quality
25
FCF yld2.3%
Earn yld-5.2%
EV/EBITDA·
ROE-3.6%
Gross mgn30%
Net mgn-28%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
중앙첨단소재 is a company specializing in the health and pharmaceutical sector, listed on the XKRX. It focuses on the development of advanced materials for medical applications.